372 related articles for article (PubMed ID: 22160727)
41. miR199a-5p inhibits hepatic insulin sensitivity via suppression of ATG14-mediated autophagy.
Li B; Wu X; Chen H; Zhuang C; Zhang Z; Yao S; Cai D; Ning G; Su Q
Cell Death Dis; 2018 Mar; 9(3):405. PubMed ID: 29540751
[TBL] [Abstract][Full Text] [Related]
42. Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes.
Jeong YT; Kim YD; Jung YM; Park DC; Lee DS; Ku SK; Li X; Lu Y; Chao GH; Kim KJ; Lee JY; Baek MC; Kang W; Hwang SL; Chang HW
Mol Pharmacol; 2013 Jul; 84(1):147-57. PubMed ID: 23658008
[TBL] [Abstract][Full Text] [Related]
43. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D
Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827
[TBL] [Abstract][Full Text] [Related]
44. Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia.
Moller DE; Chang PY; Yaspelkis BB; Flier JS; Wallberg-Henriksson H; Ivy JL
Endocrinology; 1996 Jun; 137(6):2397-405. PubMed ID: 8641192
[TBL] [Abstract][Full Text] [Related]
45. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
Huang S; Ma S; Ning M; Yang W; Ye Y; Zhang L; Shen J; Leng Y
Metabolism; 2019 Oct; 99():45-56. PubMed ID: 31295453
[TBL] [Abstract][Full Text] [Related]
46. Adipose-derived mesenchymal stem cells improve glucose homeostasis in high-fat diet-induced obese mice.
Cao M; Pan Q; Dong H; Yuan X; Li Y; Sun Z; Dong X; Wang H
Stem Cell Res Ther; 2015 Oct; 6():208. PubMed ID: 26519255
[TBL] [Abstract][Full Text] [Related]
47. Muscle-specific overexpression of heparin-binding epidermal growth factor-like growth factor increases peripheral glucose disposal and insulin sensitivity.
Fukatsu Y; Noguchi T; Hosooka T; Ogura T; Kotani K; Abe T; Shibakusa T; Inoue K; Sakai M; Tobimatsu K; Inagaki K; Yoshioka T; Matsuo M; Nakae J; Matsuki Y; Hiramatsu R; Kaku K; Okamura H; Fushiki T; Kasuga M
Endocrinology; 2009 Jun; 150(6):2683-91. PubMed ID: 19264873
[TBL] [Abstract][Full Text] [Related]
48. Acute suppression of insulin resistance-associated hepatic miR-29 in vivo improves glycemic control in adult mice.
Hung YH; Kanke M; Kurtz CL; Cubitt R; Bunaciu RP; Miao J; Zhou L; Graham JL; Hussain MM; Havel P; Biddinger S; White PJ; Sethupathy P
Physiol Genomics; 2019 Aug; 51(8):379-389. PubMed ID: 31251698
[TBL] [Abstract][Full Text] [Related]
49. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
50. Restoration of metabolic health by decreased consumption of branched-chain amino acids.
Cummings NE; Williams EM; Kasza I; Konon EN; Schaid MD; Schmidt BA; Poudel C; Sherman DS; Yu D; Arriola Apelo SI; Cottrell SE; Geiger G; Barnes ME; Wisinski JA; Fenske RJ; Matkowskyj KA; Kimple ME; Alexander CM; Merrins MJ; Lamming DW
J Physiol; 2018 Feb; 596(4):623-645. PubMed ID: 29266268
[TBL] [Abstract][Full Text] [Related]
51. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
[TBL] [Abstract][Full Text] [Related]
52. [Effect of ginsenoside Rb1 in ameliorating insulin resistance and ectopic fat deposition in obese mice induced by high fat diet].
Shang WB; Yu XZ; Wang GQ; Zhao J
Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(23):4119-23. PubMed ID: 24791501
[TBL] [Abstract][Full Text] [Related]
53. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes.
Lin X; Taguchi A; Park S; Kushner JA; Li F; Li Y; White MF
J Clin Invest; 2004 Oct; 114(7):908-16. PubMed ID: 15467829
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-181b Improves Glucose Homeostasis and Insulin Sensitivity by Regulating Endothelial Function in White Adipose Tissue.
Sun X; Lin J; Zhang Y; Kang S; Belkin N; Wara AK; Icli B; Hamburg NM; Li D; Feinberg MW
Circ Res; 2016 Mar; 118(5):810-21. PubMed ID: 26830849
[TBL] [Abstract][Full Text] [Related]
55. miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity.
Koh EH; Chernis N; Saha PK; Xiao L; Bader DA; Zhu B; Rajapakshe K; Hamilton MP; Liu X; Perera D; Chen X; York B; Trauner M; Coarfa C; Bajaj M; Moore DD; Deng T; McGuire SE; Hartig SM
Diabetes; 2018 Dec; 67(12):2541-2553. PubMed ID: 30002134
[TBL] [Abstract][Full Text] [Related]
56. Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.
Kawashima Y; Chen J; Sun H; Lann D; Hajjar RJ; Yakar S; Leroith D
Diabetologia; 2009 Jul; 52(7):1434-41. PubMed ID: 19436992
[TBL] [Abstract][Full Text] [Related]
57. Whole body ARHGAP21 reduction improves glucose homeostasis in high-fat diet obese mice.
Soares GM; Zangerolamo L; Azevedo EG; Costa-Júnior JM; Carneiro EM; Saad ST; Boschero AC; Barbosa-Sampaio HC
J Cell Physiol; 2018 Sep; 233(9):7112-7119. PubMed ID: 29574752
[TBL] [Abstract][Full Text] [Related]
58. Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high-fat diet.
Cansby E; Amrutkar M; Mannerås Holm L; Nerstedt A; Reyahi A; Stenfeldt E; Borén J; Carlsson P; Smith U; Zierath JR; Mahlapuu M
FASEB J; 2013 Sep; 27(9):3660-71. PubMed ID: 23729594
[TBL] [Abstract][Full Text] [Related]
59. Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice.
Serre-Beinier V; Toso C; Morel P; Gonelle-Gispert C; Veyrat-Durebex C; Rohner-Jeanrenaud F; Calandra T; Roger T; James RW; Montet X; Bühler L; Bosco D; Berney T
J Endocrinol; 2010 Sep; 206(3):297-306. PubMed ID: 20566490
[TBL] [Abstract][Full Text] [Related]
60. Novel canine models of obese prediabetes and mild type 2 diabetes.
Ionut V; Liu H; Mooradian V; Castro AV; Kabir M; Stefanovski D; Zheng D; Kirkman EL; Bergman RN
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E38-48. PubMed ID: 19843874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
